ANNX Q1 2026 Earnings EPS Beat Lifts Shares as PreRevenue Biotech Advances Sachem Capital Corp SCCF Q4 2025 Earnings Massive EPS Beat on Minimal Expectations SELLAS Life Sciences Group SLS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Progress DTM Q1 2026 Earnings EPS Surpasses Expectations by Nearly 10 Stock Edges Lower NNE Q1 2026 Earnings Narrower Loss Surprises as Nuclear Innovation Advances CEPT Q1 2026 Earnings Strong EPS Beat Drives Share Price Uplift